Singapore, Jan. 23 -- Sisram Medical, a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, has announced that its wholly-owned subsidiary, Sisram Medical China (Tianjin) has entered into a Memorandum of Understanding (MoU) with Sinmait Medical Technology (Beijing), a subsidiary of Shanghai Fosun Pharmaceutical (Group). This MoU establishes a framework for cooperation aimed at enhancing localization efforts in China.

This partnership is poised to accelerate Sisram's strategic implementation and business expansion in the Chinese market, strengthen the resilience of its global supply chain, and solidify the Company's position as a leader in innovation and market presence in medical aes...